Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 8343

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to require the Secretary to refer each application for review of certain tobacco products to the Tobacco Products Scientific Advisory Committee, and for other purposes.
About This Bill
Committee
Latest Action · September 22, 2020
Referred to the House Committee on Energy and Commerce.
Congress
116th (2019–2021)
Introduced
September 22, 2020
Cosponsors (7)
6D 1R
View PDF ↗

Summary

Highlight any text to annotate
Independent Advisory Committee Review of E-Cigarette Applications Act This bill requires the Food and Drug Administration (FDA) to refer to the Tobacco Products Scientific Advisory Committee certain applications for premarket review of a new tobacco product, such as an e-cigarette. (Currently, the FDA may refer an application to the committee but is generally not required to do so.) The FDA shall notify the committee when receiving such an application. If the FDA intends to issue an order on an application, the FDA shall refer the application to the committee. With respect to a referred application, the committee shall make a public vote and issue recommendations about the application. The committee must also make public a list of all applications for premarket review of new tobacco products.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.